SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Local science technology firm Illumina Inc. reported third-quarter revenue of $607 million, a 10 percent increase compared to the same period last year. But as anticipated, the company’s earnings came in under its guidance of $625 million to $630 million, and also fell short of Wall Street’s expectations.
Aya Healthcare, a San Diego-based provider of travel nursing and hospital workforce solutions, announced Nov. 1 it has acquired HealthCare Select, a vendor-neutral software company headquartered in Dana Point. Terms were not disclosed.
PURE Bioscience Inc., creator of an antimicrobial that can be safely sprayed directly on food to kill harmful bacteria, reported a 77 percent increase to its annual revenue this year.
San Diego’s MyDx Inc., a company that makes a handheld chemical analyzer for consumers, has launched a sensor chip that will allow users to test fruits, vegetables, and cannabis for pesticides and heavy metals.
Biocept Inc., a liquid biopsy test maker in San Diego, has appointed David Moskowitz to the newly created role of vice president of strategy and corporate communications.
San Diego-based Allele Biotechnology & Pharmaceuticals Inc. has raised $11 million in equity funding, according to regulatory filings.
San Diego medical device maker NuVasive Inc. reported an increase in profit for its third quarter (ended Sept. 30) compared with the same period last year.
San Diego medical device maker ResMed Inc. announced a boost to its profit in its first quarter (ended Sept. 30) compared to the same period last year.
Local science technology firm Illumina Inc. is collaborating with North Carolina-based Q2 Solutions to establish a framework for developing companion diagnostics, medical tests that are used “as a companion” to a drug to see if the drug is going to work for the patient.
The University of California, San Diego is collaborating with Indian philanthropic organization Tata Trusts to establish a research organization in India called Tata Institute for Active Genetics and Society.
San Diego drugmaker aTyr Pharma Inc. has received Fast Track designation from the U.S. Food and Drug Administration for its leading drug candidate Resolaris.
Juan Carlos Izpisua Belmonte, a professor at the Salk Institute for Biological Studies, has been awarded a $2.5 million grant to continue his work in stem cell biology and regeneration.
Organovo Holdings Inc., the San Diego firm that “bioprints” three-dimensional human tissue, is hoping to raise $25 million in a public offering of its stock.
San Diego biotech Molecular Assemblies Inc. has appointed Michael J. Kamdar as CEO and director.
The Scripps Whittier Diabetes Institute has received a $2.9 million grant from the National Institutes of Health – its third from the agency in 13 months – to study the effectiveness of algorithm-driven text messages in managing the disease among high-risk Latinos in San Diego County.